After graduating as a medical doctor at LUMC and working as an internal medicine resident not in training at Alrijne Hospital, I started as a PhD candidate in a joint appointment at both the LUMC and NKI-AvL. coordinating the Drug Rediscovery Protocol (DRUP). This is a nationwide trial in which patients are treated with off-label targeted- or immunotherapy, matched to their molecular tumor profile. I am also involved in a European consortium (PRIME-ROSE) expanding similar trials throughout Europe and I conduct research on policy-related aspects of off-label use in oncology.
